London Genetics, Diaceutics Developing Software Tools for Biomarker Research | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – London Genetics and Diaceutics today announced a partnership to develop software tools to provide pharmaceutical companies with access to academic biomarker research groups.

The software will be based on the Diaceutics' Fusion platform, a series of proprietary web applications, and London Genetics' Biomarker Pathway platform.

Terms of the deal were not announced.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.